---
title: "QUANXINHAO: Wholly-owned subsidiary plans to acquire 60% equity of Yilian Medical for 12 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255165455.md"
description: "QUANXINHAO announced that its wholly-owned subsidiary, Zhejiang QUANXINHAO Pharmaceutical Co., Ltd., intends to use its own funds of 12 million yuan to acquire 60% equity of Zhejiang Yilian Medical Equipment Co., Ltd. held by Zhejiang Qilian Medical Management Co., Ltd. Upon completion of this transaction, Yilian Medical will become a controlling subsidiary of QUANXINHAO Pharmaceutical and will be included in the company's consolidated financial statements. This transaction aims to strengthen the medical business foundation of QUANXINHAO Pharmaceutical and enhance its overall competitiveness"
datetime: "2025-08-29T09:30:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255165455.md)
  - [en](https://longbridge.com/en/news/255165455.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255165455.md)
generator: "portal-rs"
---

# QUANXINHAO: Wholly-owned subsidiary plans to acquire 60% equity of Yilian Medical for 12 million yuan

QUANXINHAO announced that its wholly-owned subsidiary, Zhejiang QUANXINHAO Pharmaceutical Co., Ltd., intends to use its own funds of 12 million yuan to acquire 60% equity in Zhejiang Yilian Medical Equipment Co., Ltd. held by Zhejiang Qilian Medical Management Co., Ltd. Upon completion of this transaction, Yilian Medical will become a controlling subsidiary of QUANXINHAO Pharmaceutical and will be included in the company's consolidated financial statements. This transaction aims to strengthen the medical business foundation of QUANXINHAO Pharmaceutical and enhance its overall competitiveness

### Related Stocks

- [000007.CN](https://longbridge.com/en/quote/000007.CN.md)

## Related News & Research

- [US SEC investigating Situational Awareness trades that led to July meltdown, source says](https://longbridge.com/en/news/296829164.md)
- [Tempus Capital takes 29% voting rights stake in KAP AG](https://longbridge.com/en/news/296889345.md)
- [Xtract One CEO Evans flags “vanity metrics” in weapons detection, urges focus on capture rates](https://longbridge.com/en/news/296946614.md)
- [Fluidra director Bruce Walker Brooks sells EUR 199,904.04 in shares](https://longbridge.com/en/news/296872380.md)
- [Spear REIT completes Watergate Centre acquisition in Cape Town](https://longbridge.com/en/news/297158942.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**